TORONTO--(BUSINESS WIRE)--
Acerus Pharmaceuticals Corporation (TSX:ASP) will announce its third
quarter 2018 financial and operating results on Tuesday November 6, 2018
before market opens. The company will host a conference call on Tuesday,
November 6, 2018 at 8:30 a.m. Eastern Time.
To access the call live, please dial 416-340-2216 or 1-800-377-0758.
Listeners are encouraged to dial in 10 minutes before the call begins to
avoid delays. A replay of the conference call will be available until
11:59 p.m. Eastern Time on Tuesday, November 13, 2018 by dialing
905-694-9451 or 1-800-408-3053, using access code: 9812622#.
About Acerus
Acerus Pharmaceuticals Corporation is a Canadian-based specialty
pharmaceutical company focused on the development, manufacture,
marketing and distribution of innovative, branded products that improve
patient experience, with a primary focus in the field of men’s and
women’s health. The Company commercializes its products via its own
salesforce in Canada, and through a global network of licensed
distributors in the U.S. and other territories.
Acerus’ shares trade on Toronto Stock Exchange under the symbol “ASP”.
For more information, visit www.aceruspharma.com
and follow us on Twitter and Linkedin.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20181030005931/en/
Acerus Pharmaceuticals Corporation
Ed Gudaitis, (905)
817-8194
President & CEO
egudaitis@aceruspharma.com
Source: Acerus Pharmaceuticals Corporation